Bupropion and Restless Legs Syndrome: A Randomized Controlled Trial

References

1. ↵
   Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160(14): 2137–41.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4(2): 101–19.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms, And Treatment) Primary Care Study. Sleep Med 2004; 5(3): 237–46.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004; 75(2): 226–30.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008; 170(1): 35–42.

   OpenUrl
6. ↵
   Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005; 58(6): 510–4.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43(1): 70–5.

   OpenUrlCrossRefPubMed
8. ↵
   Kim SW, Shin IS, Kim JM, Yang SJ, Shin HY, Yoon JS. Bupropion may improve restless legs syndrome: a report of three cases. Clin Neuropharmacol 2005; 28(6): 298–301.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4(2): 121–32.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo- controlled study. Mov Disord 2004; 19(12): 1414–23.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006; 67(6): 1034–9.

    OpenUrlAbstract/FREE Full Text
12. ↵
    Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999; 319(7211): 670–4.

    OpenUrlAbstract/FREE Full Text